van Golen KL - Search Results

1

Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer.

Mills J, Oliver A, Sherwin JC, Frydenberg M, Peters JS, Costello A, Harewood L, Love C, Redgrave N, van Golen KL, Bailey M, Pedersen J. Mills J, et al. Among authors: van golen kl. Pathology. 2012 Oct;44(6):513-8. doi: 10.1097/PAT.0b013e3283581780. Pathology. 2012. PMID: 22935975

2

Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.

Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Kleer CG, et al. Among authors: van golen kl. Am J Pathol. 2002 Feb;160(2):579-84. doi: 10.1016/S0002-9440(10)64877-8. Am J Pathol. 2002. PMID: 11839578 Free PMC article.

3

Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase.

Hall CL, Dubyk CW, Riesenberger TA, Shein D, Keller ET, van Golen KL. Hall CL, et al. Among authors: van golen kl. Neoplasia. 2008 Aug;10(8):797-803. doi: 10.1593/neo.08380. Neoplasia. 2008. PMID: 18670640 Free PMC article.

4

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.

Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. Kleer CG, et al. Among authors: van golen kl. Breast Cancer Res Treat. 2005 Sep;93(2):101-10. doi: 10.1007/s10549-005-4170-6. Breast Cancer Res Treat. 2005. PMID: 16187229 Free article.

5

RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility.

Yao H, Dashner EJ, van Golen CM, van Golen KL. Yao H, et al. Among authors: van golen kl, van golen cm. Oncogene. 2006 Apr 13;25(16):2285-96. doi: 10.1038/sj.onc.1209260. Oncogene. 2006. PMID: 16314838

6

Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.

Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Lin M, et al. Among authors: van golen kl. Mol Cancer. 2005 Jun 21;4(1):21. doi: 10.1186/1476-4598-4-21. Mol Cancer. 2005. PMID: 15969750 Free PMC article.

7

Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. van Golen KL, et al. Clin Exp Metastasis. 2002;19(4):301-11. doi: 10.1023/a:1015518114931. Clin Exp Metastasis. 2002. PMID: 12090470 Free article.

8

Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts.

Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD. Kleer CG, et al. Among authors: van golen kl. Mod Pathol. 2002 Jul;15(7):759-64. doi: 10.1038/modpathol.3880602. Mod Pathol. 2002. PMID: 12118114

9

Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. van Golen KL, et al. Mol Cancer Ther. 2002 Jun;1(8):575-83. Mol Cancer Ther. 2002. PMID: 12479217

10

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD. van Golen KL, et al. Clin Cancer Res. 1999 Sep;5(9):2511-9. Clin Cancer Res. 1999. PMID: 10499627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters